These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313 [TBL] [Abstract][Full Text] [Related]
3. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. Bianchi P; Ciani E; Guidi S; Trazzi S; Felice D; Grossi G; Fernandez M; Giuliani A; Calzà L; Bartesaghi R J Neurosci; 2010 Jun; 30(26):8769-79. PubMed ID: 20592198 [TBL] [Abstract][Full Text] [Related]
4. SSRIs probably counteract premenstrual syndrome by inhibiting the serotonin transporter. Eriksson E J Psychopharmacol; 2014 Feb; 28(2):173-4. PubMed ID: 24449218 [No Abstract] [Full Text] [Related]
5. Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome. Guidi S; Stagni F; Bianchi P; Ciani E; Ragazzi E; Trazzi S; Grossi G; Mangano C; Calzà L; Bartesaghi R Brain Pathol; 2013 Mar; 23(2):129-43. PubMed ID: 22817700 [TBL] [Abstract][Full Text] [Related]
6. A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice. Böer U; Noll C; Cierny I; Krause D; Hiemke C; Knepel W Eur J Pharmacol; 2010 May; 633(1-3):33-8. PubMed ID: 20122921 [TBL] [Abstract][Full Text] [Related]
7. Response from Thelma Lovick. Lovick T J Psychopharmacol; 2014 Feb; 28(2):174-5. PubMed ID: 24449219 [No Abstract] [Full Text] [Related]
8. Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine. Browne CA; Falcon E; Robinson SA; Berton O; Lucki I Int J Neuropsychopharmacol; 2018 Feb; 21(2):164-174. PubMed ID: 29020387 [TBL] [Abstract][Full Text] [Related]
9. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness. Naudon L; El Yacoubi M; Vaugeois JM; Leroux-Nicollet I; Costentin J Brain Res; 2002 May; 936(1-2):68-75. PubMed ID: 11988231 [TBL] [Abstract][Full Text] [Related]
10. Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring. Rayen I; Steinbusch HW; Charlier TD; Pawluski JL Psychoneuroendocrinology; 2013 Sep; 38(9):1618-29. PubMed ID: 23399049 [TBL] [Abstract][Full Text] [Related]
11. Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids. Pinna G; Costa E; Guidotti A Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6222-5. PubMed ID: 15069199 [TBL] [Abstract][Full Text] [Related]
12. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. Cabrera-Vera TM; Garcia F; Pinto W; Battaglia G J Pharmacol Exp Ther; 1997 Jan; 280(1):138-45. PubMed ID: 8996191 [TBL] [Abstract][Full Text] [Related]
13. Differential brain activation in exclusively homosexual and heterosexual men produced by the selective serotonin reuptake inhibitor, fluoxetine. Kinnunen LH; Moltz H; Metz J; Cooper M Brain Res; 2004 Oct; 1024(1-2):251-4. PubMed ID: 15451388 [TBL] [Abstract][Full Text] [Related]
14. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability? Ho HP; Olsson M; Westberg L; Melke J; Eriksson E Neuropsychopharmacology; 2001 May; 24(5):502-10. PubMed ID: 11282250 [TBL] [Abstract][Full Text] [Related]
15. Carcinoid syndrome unmasked by fluoxetine, a selective serotonin reuptake inhibitor. Furse RM; Green CJ; Mee AS Clin Gastroenterol Hepatol; 2008 Aug; 6(8):e27-8. PubMed ID: 18619915 [No Abstract] [Full Text] [Related]
16. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Pinna G; Dong E; Matsumoto K; Costa E; Guidotti A Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2035-40. PubMed ID: 12571361 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Pinna G; Costa E; Guidotti A Psychopharmacology (Berl); 2006 Jun; 186(3):362-72. PubMed ID: 16432684 [TBL] [Abstract][Full Text] [Related]
18. Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Stenfors C; Ross SB Life Sci; 2002 Nov; 71(24):2867-2880. PubMed ID: 12377268 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of enhancement of rat brain serotonin synthesis by acute fluoxetine administration. Badawy AA-B ; Morgan JC; Bano S; Buckland P; McGuffin P J Neurochem; 1996 Jan; 66(1):436-7. PubMed ID: 8522987 [No Abstract] [Full Text] [Related]
20. Gestational stress and fluoxetine treatment differentially affect plasticity, methylation and serotonin levels in the PFC and hippocampus of rat dams. Gemmel M; Rayen I; van Donkelaar E; Loftus T; Steinbusch HW; Kokras N; Dalla C; Pawluski JL Neuroscience; 2016 Jul; 327():32-43. PubMed ID: 27060483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]